Invivoscribe Begins Commercial Shipments of PrepQuant™ Systems, Enabling High-Sensitivity Sample Preparation for MRD Testing

Contributed by: Business Wire

Logo

Tags

Research

Medical Devices

Medical Supplies

Genetics

Biotechnology

Health

Pharmaceutical

Science

Oncology

PrepQuant

More Like This

Invivoscribe Announces the PrepQuant™ System, an Integrated Sample Preparation Platform that Standardizes and Streamlines Pre-Analytical Workflows

LabPMM® Receives New York State Approval for the NPM1 MRD Assay - Informing Therapy and Accelerating Targeted Trials

Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide

Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial

Invivoscribe® Expands IVDR Portfolio with IdentiClone® Dx IGH Assay Certification

Tracer Biotechnologies Announces Strategic Partnership with QIAGEN to Advance Blood-Based MRD Testing for Solid Tumors

Invivoscribe’s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay

PR Newswire associated0

Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development